• LAST PRICE
    0.0400
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0138/ 100
  • Ask / Lots
    0.0580/ 100
  • Open / Previous Close
    --- / 0.0400
  • Day Range
    ---
  • 52 Week Range
    Low 0.0138
    High 0.0470
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGENPF
Genix Pharmaceuticals Corp
3.0M
---
---
As of 2024-11-13

Company Information

Genix Pharmaceuticals Corporation is a life-sciences company. The Company is a formulator, manufacturer, licensor and marketer of life sciences related products with a focus on nutraceuticals and pharmaceuticals. The Company is focused on the research, development, manufacturing, licensing and selling of novel and healthcare products. These products include evidence-based, proprietary over the counter (OTC) nutraceuticals, and other single molecule generic drugs. The Company has been marketing and selling other nutraceuticals and some pharmaceutical products, such as bee propolis capsules, calcium liquid soft gels, seal oil soft gels, marine lipid soft gels, Lecithin soft gels, fish oil soft gels, EPO soft gels and spirulina powder. Its products include Ketorolac 0.5% Eye Drops, Timolol 0.5% Eye Drops, Diclofenac 0.1% Eye Drops, Moxifloxacin Hydrochloride 0.5% Eye Drops, Prednisolone Acetate 1% Eye Drops, Olopatadine 0.1% Eye Drops, and Artificial Tearssingle-molecule.

Contact Information

Headquarters
Suite 300, 1055 West Hastings StVANCOUVER, BC, Canada V6E 2E9
Phone
604-609-6198
Fax
604-710-9461

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.0M
Revenue (TTM)
$4.0K
Shares Outstanding
59.2M
Genix Pharmaceuticals Corp does not pay a dividend.
Beta
-0.48
EPS
$-0.07
Book Value
$-0.02
P/E Ratio
---
Price/Sales (TTM)
744.0
Price/Cash Flow (TTM)
---
Operating Margin
-97,277.39%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.